Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Clinical and Experimental Rheumatology
|
May 10, 2016
Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials
Gene V Wallenstein, Keith S Kanik, Bethanie Wilkinson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 23, 2019
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study
Désirée van der Heijde, Vibeke Strand, Yoshiya Tanaka, et al.
Arthritis Research & Therapy
|
June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Stanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
Clinical Pharmacology in Drug Development
|
July 14, 2016
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients
Tong Zhu, James Keirns, Corrie Howieson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Eli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 30, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 10, 2020
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study)
Stanley Cohen, Katie Tuckwell, Tamiko R Katsumoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 5, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Rheumatology and Therapy
|
June 20, 2021
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
Stanley Cohen, Alvin F Wells, Jeffrey R Curtis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Clinical and Experimental Rheumatology
|
May 10, 2016
Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials
Gene V Wallenstein, Keith S Kanik, Bethanie Wilkinson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 23, 2019
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study
Désirée van der Heijde, Vibeke Strand, Yoshiya Tanaka, et al.
Arthritis Research & Therapy
|
June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
Stanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
Clinical Pharmacology in Drug Development
|
July 14, 2016
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients
Tong Zhu, James Keirns, Corrie Howieson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Eli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 30, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 10, 2020
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study)
Stanley Cohen, Katie Tuckwell, Tamiko R Katsumoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 5, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Rheumatology and Therapy
|
June 20, 2021
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
Stanley Cohen, Alvin F Wells, Jeffrey R Curtis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2
Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Page
of 12